2018
DOI: 10.1016/j.jcv.2018.05.008
|View full text |Cite
|
Sign up to set email alerts
|

Accumulated pre-switch resistance to more recently introduced one-pill-once-a-day antiretroviral regimens impacts HIV-1 virologic outcome

Abstract: 12-month VL suppression with Complera/Stribild was high, suggesting that OPODs remain options even for experienced patients. Clinicians should consider resistance history before switching to OPODs and continue to focus on improving adherence.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5

Relationship

3
2

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 37 publications
0
6
0
Order By: Relevance
“…Analyses included all available HIV-1 sequences that were ever obtained for drug resistance testing as part of routine clinical care of individuals with HIV residing in Rhode Island and in care at the adult Immunology Center or pediatric Hasbro Clinic, the two largest HIV Centers in Rhode Island, which serve $80% of the state's HIV population [21,51,54]. Demographic, clinical, and laboratory de-identified data were obtained from individuals' clinical charts, collected through routine clinical care, and included age, gender, race, ethnicity, behavior risk factors, and country of birth.…”
Section: Hiv-1 Sequences and Associated Datamentioning
confidence: 99%
“…Analyses included all available HIV-1 sequences that were ever obtained for drug resistance testing as part of routine clinical care of individuals with HIV residing in Rhode Island and in care at the adult Immunology Center or pediatric Hasbro Clinic, the two largest HIV Centers in Rhode Island, which serve $80% of the state's HIV population [21,51,54]. Demographic, clinical, and laboratory de-identified data were obtained from individuals' clinical charts, collected through routine clinical care, and included age, gender, race, ethnicity, behavior risk factors, and country of birth.…”
Section: Hiv-1 Sequences and Associated Datamentioning
confidence: 99%
“…HIV-1 sequences and associated data Available HIV-1 sequences obtained by the end of 2020 through drug resistance testing during routine clinical care of individuals with HIV residing in Rhode Island (RI) were utilized for analysis of cluster dynamics [11,30,31]. Demographic, clinical and laboratory deidentified data were obtained from medical records, and included sex, age at sequencing, race, ethnicity, men who have sex with men (MSM) status, prior illegal substance use, prior incarceration, prior mental health diagnoses, country of birth, year of HIV-1 diagnosis and year of sequencing.…”
Section: Methodsmentioning
confidence: 99%
“…Characteristics and major patterns of the HIV-1 epidemic in Rhode Island have been presented elsewhere [11,[29][30][31]. Here, a total of 2153 sequences were used, representing the statewide epidemic (including all available RI sequences, from >70% of diagnosed individuals [29]).…”
Section: Cohort Datasetmentioning
confidence: 99%
“…What are the options to decrease the pill burden in second-line antiretroviral therapy? Most of the studies simplifying ART in terms of pill burden in ART-experienced PWH are when they have had an undetectable HIV viral load for at least 6 months (as an induction-maintenance strategy) mainly in HICs [40][41][42][43]. However, there would be significant patient and population level benefits to a robust simplified secondline FDC, applicable in LMICs.…”
Section: Simplified Second-line Therapymentioning
confidence: 99%